Page 8 - Fortis Healthcare

Yes Bank sells 2% shares in Fortis Healthcare, stake down to 15%

Shares of Fortis Healthcare were trading 1.25 per cent lower at Rs 158.20 apiece on BSE

In battle for control of Fortis Healthcare, it is advantage shareholders

TPG Capital, Manipal Health Enterprises likely to make voluntary open offers

Fortis Healthcare trades flat despite poor December-quarter earnings

The company also reported its September quarter net loss at Rs 236.1 million

NSE to stop derivative trading in Fortis if results not filed by March 1

no futures and options contracts of Fortis shall be available for trading in equity derivatives segment from March 29

Fortis Healthcare: The faint-hearted can wait for more clarity

The Fortis-RHT deal and core business growth can drive earnings, but many reasons to remain cautious too

Fortis Healthcare, Religare Enterprises down upto 8% on talk of fraud probe

Religare Enterprises locked in lower circuit of 5% at Rs 60, while Fortis Healthcare was trading 5% lower at Rs 139, after falling 8% to Rs 135 on the BSE in intra-day trade.

Fortis promoter holding dips to 8.85% on invoking 132 mn pledged shares

Last week, the SC had allowed financial institutions, with whom shares of Fortis Healthcare Limited have been pledged

Sebi to probe Fortis deals, asks company to provide information by Feb 26

Replying to notices, Fortis Healthcare said its wholly-owned arm Fortis Hospitals had deployed funds to the tune of Rs 4.73 billion as secured short-term investments to group firms of its promoters

Fortis Healthcare under pressure after SC allows FIs to sell pledged shares

The stock slipped 20% to Rs 115 in noon deal trade, falling 24% from its intra-day high of Rs 151 on BSE on back of heavy volumes.

Malvinder and Shivinder Singh: The difficulties of being good at business

As the Daiichi Sankyo-Ranbaxy controversy enters the last lap, the Singh brothers may be ruing their inability to run professional businesses

HC order on Daiichi arbitration: Fortis accepts Singh Brothers' resignation

The directors will meet on February 28 to take up the matter, it added

Fortis issue under ICAI consideration zone as promoters take out Rs 4.73 bn

Fortis Healthcare said its wholly-owned arm Fortis Hospitals had deployed funds to the tune of Rs 473 crore as secured short-term investments to group firms of its promoters

Why the billionaire Singh brothers could be entering endgame phase

Combined m-cap of companies promoted by Singh brothers down to Rs 83 bn from Rs 206 bn on eve of Ranbaxy sale

Fortis Healthcare turns volatile after promoters Singh brothers resignation

The stock opened 2% lower at Rs 123 on BSE, bouncing back 28% to hit high of Rs 157 in intra-day trade, trading at Rs 147 at 09:48 AM.

Malvinder Singh and Shivinder Singh quit Fortis Healthcare board

Board of directors to discuss matter on February 13

Malvinder Singh and Shivinder Singh resign from Fortis Healthcare board

Malvinder Singh resigns as executive chairman of Fortis Healthcare

Health care industry needs self-regulation: Fortis Healthcare CEO

Bhavdeep Singh says there is trust deficit everywhere and steps need to be taken

Supreme Court refuses permission to sell shares in Fortis Healthcare

Shares of Fortis Healthcare closed 5.44 percent lower to trade at Rs 146 per share on Thursday after the Supreme Court refused to afford any relief to promoters Malvinder Singh and Shivinder Sing and lender banks of the company to part with their encumbered shareholdings. Encumbered assets are those shares that are pledged or offered as collateral to a lender.Directing the applicants to maintain status quo on shareholding, the apex court clarified that its August 11 order not to sell their stock, included both encumbered and unencumbered assets and extended to even lender banks and shares pledged to them by the company. Japanese pharmaceutical giant Daiichi Sankyo, had earlier in August moved the Supreme Court to block the sale of Fortis shares by promoters and other entities in order to preserve assets in the company to realise a Rs 2,562 crore Singapore arbitration award against the Singh brothers in favour of the foreign company. On Thursday, Axis Bank and Yes Bank - which also ...

Fortis Healthcare tanks 6% as SC bars promoters from selling pledged shares

SC reaffirmed that Singh brothers cannot sell both encumbered and non-encumbered assets

Why big investors, brokerages like Fortis Healthcare

The Fortis Healthcare stock was up 8 per cent after buy ratings from brokerages and on news that Rakesh Jhunjhunwala picked up a stake in the company on Tuesday. For a company whose stock has taken a beating - down almost a third per cent in about three months, due to issues at the promoter group that have little direct impact for Fortis, these latest developments are a welcome. So, why this positive stance on Fortis?Goldman Sachs, which has a buy rating on the company, believes the mature hospitals and better occupancies will lead to margin expansion to the tune of 280 basis points during the FY18-20 period. Flagship hospitals will drive revenues, which is pegged to grow at 11 per cent annually over the same period. Other analysts expect its revenues to grow by about 10 per cent annually led by higher volumes as well as better product (specialty) mix. About 80 per cent of the company's owned beds are five years old, which coupled with occupancies in excess of 60 per cent translates ..